Lexaria Corp. (OTC: LXRP), an aspiring producer of medical marijuana under Canada’s Marihuana for Medical Purposes Regulations (“MMPR”), recently announced new corporate policies regarding the responsible use of medical marijuana. The new policies go above and beyond those required by law and help set the standard for companies operating within the industry.

The company’s new corporate policy states that it will not knowingly sell medical marijuana containing more than 0.3% THC to any medical marijuana patient under the age of 21, unless it is in a form specifically approved by relevant government health agencies. While broadly in line with the U.S.’s alcohol consumption laws, the policies are more restrictive than Canada’s alcohol consumption laws. These policies are in effect as long as there’s a CBD-based alternative with medical properties.

In addition to restricting the sale to adults over 21 years of age, the company does not encourage nor support consuming marijuana through the act of smoking. Research has indicated that the act of burning marijuana may negatively affect the delivery of potentially helpful CBD-based compounds, and smoking any substance is not conductive to good health practices.

“Our goal is to safely help people live healthy and productive lives,” said Chris Bunka, CEO of Lexaria. “We want to be sure to do no harm and Lexaria’s policies are a big step in the right direction towards ensuring members of our community are receiving the health benefits they need.”

The company encourages people in the Canada or the U.S. who share its philosophy regarding the responsible use of medical marijuana to register on its website www.lexariaenergy.com. The company aims to build a community of like-minded, responsible medical users of marijuana who can share their experiences and knowledge with each other for the benefit of everyone.

In July, the company announced that it received final municipal zoning approval for its joint venture project with Enertopia Corp. (OTC: ENRT). The approval represents an important step in the process towards obtaining a license under Health Canada’s MMPR program. Management has not commented recently on the status of its licensing efforts.

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.